Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky, William A. Werbel, Robin K. Avery, et al.
JAMA (2021) Vol. 325, Iss. 21, pp. 2204-2204
Open Access | Times Cited: 951

Showing 1-25 of 951 citing articles:

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E G Levin, Yaniv Lustig, Carmit Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 1083
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Nassim Kamar, Florence Abravanel, Olivier Marion, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 661-662
Open Access | Times Cited: 826
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
Victoria Hall, Victor H. Ferreira, Terrance Ku, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 13, pp. 1244-1246
Open Access | Times Cited: 524
Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 378
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
Iliès Benotmane, Gabriela Gautier, Peggy Perrin, et al.
JAMA (2021) Vol. 326, Iss. 11, pp. 1063-1063
Open Access | Times Cited: 334
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
William A. Werbel, Brian J. Boyarsky, Michael T. Ou, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 9, pp. 1330-1332
Open Access | Times Cited: 331
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
Parakkal Deepak, Wooseob Kim, Michael Paley, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 11, pp. 1572-1585
Open Access | Times Cited: 289
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
A. Velleca, M.A. Shullo, K. Dhital, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 42, Iss. 5, pp. e1-e141
Open Access | Times Cited: 252
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US
Jing Sun, Qulu Zheng, Vithal Madhira, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 153-153
Open Access | Times Cited: 238
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients
Arne Sattler, Eva Schrezenmeier, U. Weber, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 14
Open Access | Times Cited: 236
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
David Cucchiari, Natalia Egri, Marta Bodro, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2727-2739
Open Access | Times Cited: 226
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Rachna T. Shroff, Pavani Chalasani, Ran Wei, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2002-2011
Open Access | Times Cited: 192
Long-Term Survival after Kidney Transplantation
Sundaram Hariharan, Ajay K. Israni, Gabriel M. Danovitch
New England Journal of Medicine (2021) Vol. 385, Iss. 8, pp. 729-743
Closed Access | Times Cited: 177
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, et al.
Nature Medicine (2021) Vol. 27, Iss. 10, pp. 1744-1751
Open Access | Times Cited: 175
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
Clément Danthu, Sébastien Hantz, Arthur Dahlem, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 9, pp. 2153-2158
Open Access | Times Cited: 160
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients
Caroline X. Qin, Linda W. Moore, Shweta Anjan, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e265-e266
Open Access | Times Cited: 155
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
Mounzer Agha, Maggie Blake, Charles Chilleo, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 147
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W. Tenforde, Manish M. Patel, Adit A. Ginde, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 9, pp. 1515-1524
Open Access | Times Cited: 145
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
Victoria Hall, Victor H. Ferreira, Matthew Ierullo, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3980-3989
Open Access | Times Cited: 143
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
Tina Schmidt, Verena Klemis, David Schub, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3990-4002
Open Access | Times Cited: 142
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 138
Population antibody responses following COVID-19 vaccination in 212,102 individuals
Helen Ward, Matthew Whitaker, Barnaby Flower, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Page 1 - Next Page

Scroll to top